Tuberous sclerosis complex

EP Henske, S Jóźwiak, JC Kingswood… - Nature reviews Disease …, 2016 - nature.com
Tuberous sclerosis complex (TSC) is an autosomal dominant disorder that affects multiple
organ systems and is caused by loss-of-function mutations in one of two genes: TSC1 or …

Regulation of mTORC1 by amino acids

L Bar-Peled, DM Sabatini - Trends in cell biology, 2014 - cell.com
The mechanistic target of rapamycin complex I (mTORC1) is a central regulator of cellular
and organismal growth, and hyperactivation of this pathway is implicated in the …

Epilepsy in the mTORopathies: opportunities for precision medicine

PB Moloney, GL Cavalleri, N Delanty - Brain communications, 2021 - academic.oup.com
The mechanistic target of rapamycin signalling pathway serves as a ubiquitous regulator of
cell metabolism, growth, proliferation and survival. The main cellular activity of the …

People with intellectual disability: what do we know about adulthood and life expectancy?

AMW Coppus - Developmental disabilities research reviews, 2013 - Wiley Online Library
Increases in the life expectancy of people with Intellectual Disability have followed similar
trends to those found in the general population. With the exception of people with severe …

TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study

PJ De Vries, E Belousova, MP Benedik, T Carter… - Orphanet journal of rare …, 2018 - Springer
Background Most evidence for TSC-associated neuropsychiatric disorders (TAND) to date
have come from small studies and case reports, and very little is known about TAND in …

Renal disease in tuberous sclerosis complex: pathogenesis and therapy

HC Lam, BJ Siroky, EP Henske - Nature Reviews Nephrology, 2018 - nature.com
Tuberous sclerosis complex (TSC) is an autosomal dominant disease characterized by
hamartomatous tumours of the brain, heart, skin, lung and kidney. Patients with TSC show a …

Tuberous sclerosis: a review of the past, present, and future

SP Uysal, M Şahin - Turkish journal of medical sciences, 2020 - journals.tubitak.gov.tr
Tuberous sclerosis complex (TSC) is an autosomal dominant, multisystem disorder that is
characterized by cellular and tissue dysplasia in several organs. With the advent of genetic …

[HTML][HTML] Tuberous sclerosis complex

H Northrup, MK Koenig, DA Pearson, KS Au - 2021 - europepmc.org
Tuberous sclerosis complex (TSC) involves abnormalities of the skin (hypomelanotic
macules, confetti skin lesions, facial angiofibromas, shagreen patches, fibrous cephalic …

TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study

B Ogórek, L Hamieh, HM Hulshof, K Lasseter… - Genetics in …, 2020 - nature.com
Purpose To perform comprehensive genoty** of TSC1 and TSC2 in a cohort of 94 infants
with tuberous sclerosis complex (TSC) and correlate with clinical manifestations. Methods …

A clinical update on tuberous sclerosis complex‐associated neuropsychiatric disorders (TAND)

PJ De Vries, L Wilde, MC De Vries… - American Journal of …, 2018 - Wiley Online Library
Tuberous sclerosis complex (TSC) is associated with a wide range of behavioral,
psychiatric, intellectual, academic, neuropsychological, and psychosocial difficulties, which …